Article citationsMore>>

C. Gridelli, F. Ciardiello, R. Feld, et al., “International Multicenter Randomized Phase III Study of First-Line Erlotinib (E) Followed by Second-Line Cisplatin Plus Gemcitabine (CG) versus First-Line CG followed by Second-Line E in Advanced Non-Small Cell Lung Cancer (aNSCLC): The TORCH Trial,” Journal of Clinical Oncology, Vol. 28, No. 15s, 2010, Abstract 7508.

has been cited by the following article: